|
|
|
Corporate Profile: Sunesis
Pharmaceuticals
| Summary: |
Founded in
June 1998, Sunesis Pharmaceuticals is committed to
becoming a leader in the discovery of important new
pharmaceutical products for the treatment of human
disease. They are doing this by applying a revolutionary
new approach to drug discovery that is based on a
novel chemical methodology combined with critical
insights into the nature of molecular recognition
between natural macromolecules and their substrates
or ligands. |
| Address:
|
341 Oyster Point Blvd.
South San Francisco, CA 94080 |
| Phone
#'s: |
Main |
(650) 266-3500 |
| Human Resources |
not known |
| Investor Relations |
not known |
| Fax
#'s: |
Main |
(650) 266-3505 |
| Human Resources |
(650) 266-3503 |
| Investor Relations |
not known |
| Financial
information: |
| Since
its founding in 1998, Sunesis has completed five
rounds of private financing totaling approximately
$114 million. |
| Number
of employees: |
| not
known |
| Patent
position: |
U.S. patents: 1976-present: patent
link. |
|
|
|
